(Q42601467)

3 November 2017

title

Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study (English)

1 reference

3 November 2017

0 references

1 reference

ChEBI release 2020-05-28

1 reference

2

1 reference

3 November 2017

Samuel R. Chamberlain

series ordinal

3

1 reference

3 November 2017

1

Jon E Grant

1 reference

3 November 2017

4

Suck Won Kim

1 reference

3 November 2017

publication date

19 May 2011

1 reference

3 November 2017

1 reference

3 November 2017

volume

218

1 reference

3 November 2017

issue

3

1 reference

3 November 2017

page(s)

493-502

1 reference

Inhibition and the right inferior frontal cortex

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Abuse potential of dronabinol (Marinol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

The neuropsychiatry of impulsivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Reduced brain white matter integrity in trichotillomania: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Characteristics of 60 adult chronic hair pullers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Decision-making during gambling: an integration of cognitive and psychobiological approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Group treatment for trichotillomania: behavior therapy versus supportive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Escitalopram treatment of trichotillomania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Factor analysis of the Massachusetts General Hospital Hairpulling Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

DBT-enhanced habit reversal treatment for trichotillomania: 3-and 6-month follow-up results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Decision-making processes following damage to the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Quality of life and clinical severity in pathological skin picking and trichotillomania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

The acute effects of cannabinoids on memory in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

The assessment of trichotillomania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

Cannabinoid receptors and their role in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

The Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version (MIST-A): Development of an Instrument for the Assessment of “Focused” and “Automatic” Hair Pulling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

On the ability to inhibit simple and choice reaction time responses: A model and a method

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00213-011-2347-8

21 January 2018

12 December 2020

Fluoxetine for trichotillomania: an open clinical trial

1 reference

12 December 2020

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

1 reference

12 December 2020

A controlled trial of venlafaxine in trichotillomania: interim phase I results

1 reference

12 December 2020

A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania

1 reference

12 December 2020

Long-term treatment of trichotillomania (hair pulling)

1 reference

12 December 2020

Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both?

1 reference

12 December 2020

Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.

1 reference

12 December 2020

Clinical characteristics of trichotillomania and its response to fluoxetine

1 reference

12 December 2020

Pediatric trichotillomania: descriptive psychopathology and an open trial of cognitive behavioral therapy

1 reference

12 December 2020

Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery

1 reference

12 December 2020

The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization.

1 reference

12 December 2020

The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses

1 reference

12 December 2020

10.1007/S00213-011-2347-8

Identifiers

DOI

1 reference

Dimensions Publication ID

3 November 2017

1029859783

0 references

1 reference